Catalent Cell and Gene Content

  1. Are Real-Time Gene Therapy Test Results Possible?

    Along with the complexities of vaccine and viral-based gene therapy process development comes the need for analytical techniques that can help assess quality parameters, especially in real-time.

  2. Manufacturing Strategies To Industrialize Autologous Cell Therapies

    While the first autologous cell therapy commercial products have shown tremendous clinical success, scaling out these therapies while considering individual patient processes is a new challenge.

  3. Is Your Partner Prepared For Commercial-Scale Cell Therapies?

    In this review, we discuss a few attributes that should be considered when planning manufacturing at scale for your cell therapy.

  4. Integrated Solutions For Advanced Therapeutics

    Our development expertise across all gene therapy modalities (AAV, lentivirus, oncolytic virus, etc.) and proven clinical through commercial scale-up capabilities will provide full life cycle support of your life-saving therapeutic.

  5. Navigating The Path To The Clinic And Beyond For Gene Therapies

    A gene therapy’s path from the research lab to the clinic and, ultimately, the market requires manufacturing processes that will meet the regulatory requirements and logistics to get therapies to clinical trial sites.